Video Experimental Relacionado
Updated: Sep 10, 2025
12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
9.6K
Relación estructura-función de la escisión de la proteína S en la inmunoterapia intratumoral con el virus del mosaico
Andrea Simms1,2,3,4, Jessica Fernanda Affonso de Oliveira1,2,3,4, Narek Minasov1,2,3,4
1Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA. nsteinmetz@ucsd.edu.
Biomaterials science
|August 26, 2025
Resumen
El virus del mosaico de Cowpea (CPMV) es prometedor para la inmunoterapia del cáncer. Los cambios estructurales en su proteína de capa pequeña no afectaron su capacidad para combatir tumores o estimular respuestas inmunes, lo que respalda su traducción clínica.
Área de la Ciencia:
- Virología
- Inmunología
- En el campo de la oncología
Sus antecedentes:
- Se está explorando el virus del mosaico de Cowpea (CPMV) para la inmunoterapia intratumoral.
- Se necesita más investigación para apoyar su traducción clínica.
Objetivo del estudio:
- Evaluar el impacto de las desviaciones estructurales en la proteína de la capa pequeña (S) del CPMV en su potencial terapéutico.
- Evaluar si estos cambios estructurales afectan la eficacia antitumoral, la captación de células inmunes y los perfiles de citoquinas.
Principales métodos:
- Se han investigado variaciones estructurales en la proteína del revestimiento CPMV S.
- Evaluó los efectos de estas variaciones en el rendimiento de CPMV en modelos preclínicos.
Principales resultados:
- Las desviaciones estructurales en la proteína del revestimiento CPMV S no comprometieron su eficacia antitumoral.
- La absorción de células inmunes y los perfiles de citoquinas no se vieron afectados por las modificaciones estructurales.
Conclusiones:
- CPMV sigue siendo un candidato viable para la inmunoterapia intratumoral, incluso con alteraciones en su proteína de capa S.
- Estos hallazgos refuerzan la lógica para avanzar en las inmunoterapias contra el cáncer basadas en CPMV.
Videos de Conceptos Relacionados
01:27Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
01:40Cell-mediated Immune Responses
72.4K
Overview
72.4K
01:29Immune Response Against Viral Pathogens
917
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
917
01:03Rous Sarcoma Virus (RSV) and Cancer
5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.4K
00:56Viral Structure
63.6K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
63.6K